Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025)
Inventiva (IVA) posted quarterly Other Non-Current Liabilities of $1.4 million for Q4 2025, up 25.93% year-over-year from $1.1 million in Q4 2024, and down 99.89% quarter-over-quarter from $1.3 billion in Q2 2025.
Inventiva (IVA) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
Inventiva's Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities rose 25.93% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (up 25.93% YoY), while the FY2025 annual figure was $1.4 million, up 25.93% from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $1.4 million, down from $1.3 billion in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $1.3 billion in Q2 2025, with the low at $1.1 million in Q4 2024.
- The 4-year median for Other Non-Current Liabilities is $1.4 million (2025), against an average of $183.6 million.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities dropped 0.68% in 2024, then soared 114588.35% in 2025.
- Inventiva's Other Non-Current Liabilities stood at $2.9 million in 2021, then sank by 61.21% to $1.1 million in 2023, then fell by 0.68% to $1.1 million in 2024, then advanced by 25.93% to $1.4 million in 2025.
- Business Quant data shows IVA's Other Non-Current Liabilities at $1.4 million in Q4 2025, $1.3 billion in Q2 2025, and $1.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.27 Bn |
| Dec 31, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Jun 30, 2021 | 2.86 Mn |
| Mar 31, 2021 | 2.87 Mn |
| Dec 31, 2020 | 2.83 Mn |
| Jun 30, 2020 | 632,238.11 |
| Dec 31, 2019 | 635,353.52 |